Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization Versus Medical Rate Control

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 266 participants.

Also called NCT06833138

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 266 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06833138
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06833138. Randomized; single masking; primary purpose treatment. Start 2025-09-10 (actual); primary completion 2029-05-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization Versus Medical Rate Control
Acronym
HF-RELIEF
Condition
Atrial Fibrillation, Persistent
Intervention (Procedure)
pacemaker implantation
Intervention (Procedure)
atrioventricular node ablation
Intervention (Device)
Pacemaker programming
Lead sponsor
French Cardiology Society (class: other)
Collaborator
Medtronic France SAS (class: industry)

Record details

Record id
cardio:ct-nct06833138
Content hash
ed059daa3651e1c44faa0cea314d5d09ab214855967e5d16229d456b58f451a4